NTLA logo

Intellia Therapeutics, Inc. (NTLA) price to sales ratio

PS ratio:

30.90+1.85(+6.37%)
July 25, 2025

Summary

  • As of today (July 27, 2025), NTLA price to sales ratio is 30.90, with a rise of +1.85 (+6.37%) during the most recent trading session on July 25, 2025.
  • Over the past year, NTLA PS ratio has dropped by -25.34 (-45.06%).
  • NTLA PS ratio is now -91.96% below its all-time high of 384.29.

Performance

NTLA PS ratio Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

OtherNTLAvaluation metrics

PS ratio Formula

P/S =  
Market capitalization
TTM Revenue

NTLA PS ratio Trends

PeriodPeriodPS ratioPS ratioPricePriceMarket capMarket capTTM revenueTTM revenue
todaytoday+6.4%+6.4%+6.4%-21.3%
1 m1 month+42.2%+42.2%+42.2%-
3 m3 months+63.6%+63.6%+63.6%-21.3%
6 m6 months+59.9%+23.7%+25.9%-
ytdytd+50.4%+16.6%+18.5%-
1 y1 year-45.1%-48.5%-45.5%-13.4%
5 y5 years+39.4%-29.0%+25.2%-10.2%

NTLA PS ratio Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month32.37-4.5%21.32+44.9%
3 m3-month32.37-4.5%15.62+97.8%
6 m6-month32.37-4.5%14.27+116.5%
1 y1-year59.02-47.6%14.27+116.5%
3 y3-year120.20-74.3%14.27+116.5%
5 y5-year384.29-92.0%14.27+116.5%
alltimeall time384.29-92.0%11.06+179.4%

NTLA PS ratio History

DateValue
2025
30.90(+50.4%)
2024
20.54(-73.9%)
2023
78.76(+35.1%)
2022
58.31(-78.1%)
2021
266.46(+328.9%)
DateValue
2020
62.13(+263.8%)
2019
17.08(-12.6%)
2018
19.54(-37.4%)
2017
31.19(+8.9%)
2016
28.65

FAQ

  • What is Intellia Therapeutics, Inc. price to sales ratio?
  • What is the all time high PS ratio for Intellia Therapeutics, Inc.?
  • What is NTLA price to sales ratio year-to-date change?
  • What is Intellia Therapeutics, Inc. PS ratio year-on-year change?

What is Intellia Therapeutics, Inc. price to sales ratio?

The current PS ratio of NTLA is 30.90

What is the all time high PS ratio for Intellia Therapeutics, Inc.?

Intellia Therapeutics, Inc. all-time high price to sales ratio is 384.29

What is NTLA price to sales ratio year-to-date change?

Intellia Therapeutics, Inc. price to sales ratio has changed by +10.36 (+50.44%) since the beginning of the year

What is Intellia Therapeutics, Inc. PS ratio year-on-year change?

Over the past year, NTLA price to sales ratio has changed by -25.34 (-45.06%)
On this page